115 Participants Needed

Noninvasive Spinal Stimulation for Stroke Recovery

KM
SP
Overseen BySara Prokup, DPT
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Shirley Ryan AbilityLab
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study has two interventional components, the first is a cross-over design and the second is a randomized control trial. Both will evaluate the effectiveness of transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals with hemiplegia due to stroke.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking medications that affect motor system excitability, like amphetamines or lorazepam.

What data supports the effectiveness of this treatment for stroke recovery?

Research shows that transcutaneous electrical spinal cord stimulation (tSCS) can activate spinal networks to improve walking in stroke patients, as seen in a study where patients with hemiparesis showed clinically important improvements in walking after using tSCS. Additionally, similar noninvasive spinal stimulation techniques have been effective in enhancing motor recovery in spinal cord injury, suggesting potential benefits for stroke rehabilitation.12345

Is noninvasive spinal stimulation safe for humans?

Research on transcutaneous electrical spinal cord stimulation (tSCS) suggests it is generally safe for humans, as it is a non-invasive method used in rehabilitation for various conditions, including stroke and spinal cord injuries. Studies have shown it can activate spinal circuits and improve motor functions without significant safety concerns.12367

How does the treatment of noninvasive spinal stimulation for stroke recovery differ from other treatments?

Noninvasive spinal stimulation for stroke recovery is unique because it uses electrical stimulation to activate spinal networks that control walking, which can improve walking ability in stroke patients. This approach is non-invasive and targets the spinal cord directly, unlike traditional therapies that may focus on physical exercises alone.12356

Research Team

Arun Jayaraman, PT, PhD

Arun Jayaraman, PT, PhD

Principal Investigator

Shirley Ryan AbilityLab

Eligibility Criteria

This trial is for adults over 18 who have hemiplegia from a stroke at least 6 months ago and need some help walking. They shouldn't be getting regular physical therapy, must have doctor's approval to join, and can't be pregnant or nursing. People with seizures unrelated to stroke, certain neurological conditions, severe muscle tightness in legs, recent Botox in the leg, metal implants in head/face or using heart devices like pacemakers are excluded.

Inclusion Criteria

I need someone's help to walk because of balance or coordination issues.
I am not currently undergoing regular physical therapy.
I am 18 years old or older.
See 4 more

Exclusion Criteria

I currently have a urinary tract infection.
You have a pacemaker implanted in your heart.
I do not have a brain injury or neurological condition affecting the study.
See 22 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Exploratory Phase

Identify optimal stimulation parameters and gait training protocol for each individual patient with stroke

4 weeks

Treatment

Participants undergo transcutaneous spinal cord stimulation and gait training to evaluate short-term and long-term effects on gait symmetry and performance

4 weeks
Multiple visits for interventions and assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments at 3 months post-intervention

3 months

Treatment Details

Interventions

  • Conventional gait training
  • Exploratory Phase
  • Noninvasive spinal stimulation
  • Noninvasive spinal stimulation with gait training
  • Sham
Trial OverviewThe study tests if non-invasive spinal cord stimulation improves walking and balance in people with hemiplegia after a stroke. It has two parts: one where participants try different methods one after another (cross-over), and another where they're randomly assigned to either get the real treatment or a pretend (sham) version.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Aim 2: Gait Training + StimulationExperimental Treatment2 Interventions
Up to 60 min of locomotion training with transcutaneous spinal cord stimulation. However, the amount of time spent in side-lying locomotion training, treadmill training and over ground training will depend on individual tolerance and progression.
Group II: Aim 1: Gait Training + StimulationExperimental Treatment2 Interventions
Up to 60 min of locomotion training with transcutaneous spinal cord stimulation. However, the amount of time spent in side-lying locomotion training, treadmill training and over ground training will depend on individual tolerance and progression.
Group III: Aim 1: Gait Training + Sham StimulationActive Control2 Interventions
Up to 30 seconds of transcutaneous spinal cord stimulation in order to blind them to the intervention while performing locomotion training. However, the amount of time spent in side-lying locomotion training, treadmill training and over ground training will depend on individual tolerance and progression.
Group IV: Aim 2: Gait Training + Sham StimulationActive Control2 Interventions
Up to 30 seconds of transcutaneous spinal cord stimulation in order to blind them to the intervention while performing locomotion training. However, the amount of time spent in side-lying locomotion training, treadmill training and over ground training will depend on individual tolerance and progression.

Conventional gait training is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Conventional Gait Training for:
  • Stroke Rehabilitation
  • Hemiplegia
  • Gait Disorders
🇪🇺
Approved in European Union as Conventional Gait Training for:
  • Stroke Rehabilitation
  • Neurological Rehabilitation
  • Physical Therapy
🇨🇦
Approved in Canada as Conventional Gait Training for:
  • Stroke Rehabilitation
  • Hemiplegia
  • Gait Disorders

Find a Clinic Near You

Who Is Running the Clinical Trial?

Shirley Ryan AbilityLab

Lead Sponsor

Trials
212
Recruited
17,900+

University of California, Los Angeles

Collaborator

Trials
1,594
Recruited
10,430,000+

Findings from Research

Transcutaneous electrical spinal cord stimulation (tSCS) effectively activates spinal networks to improve walking patterns in patients with hemiparesis, as demonstrated in a study involving patients 3-11 months post-stroke over a 2-week treatment period.
Patients receiving tSCS showed significant improvements in walking parameters compared to a control group that received sham stimulation, indicating that this technology can be a valuable tool in rehabilitation for locomotion disorders.
A New Technology for Recovery of Locomotion in Patients after a Stroke.Moshonkina, TR., Zharova, EN., Ananev, SS., et al.[2023]
Cervical transcutaneous spinal cord stimulation (tSCS) can effectively activate sensory fibers at lower stimulation intensities when the cathode electrode is positioned at the C7 or T1 vertebra, compared to C6, which may enhance rehabilitation outcomes for upper-limb motor recovery after spinal cord injury.
Using smaller electrode sizes not only lowers the activation threshold for sensory fibers but also optimizes the recruitment of these fibers before α-motor fibers, suggesting a strategic approach to improve hand muscle activation during tSCS therapy.
Optimizing sensory fiber activation during cervical transcutaneous spinal stimulation using different electrode configurations: A computational analysis.de Freitas, RM., Capogrosso, M., Nomura, T., et al.[2022]
In a double-blinded study involving 2 male patients with incomplete spinal cord injury, anodal transcutaneous spinal direct current stimulation (tsDCS) improved all measured outcomes, including gait and balance, while cathodal tsDCS showed mixed results.
Both types of tsDCS were able to modulate corticospinal excitability, indicating that this non-invasive method could be a promising approach for enhancing rehabilitation in patients with spinal cord injuries.
Spinal direct current stimulation with locomotor training in chronic spinal cord injury.Abualait, TS., Ibrahim, AI.[2021]

References

A New Technology for Recovery of Locomotion in Patients after a Stroke. [2023]
Optimizing sensory fiber activation during cervical transcutaneous spinal stimulation using different electrode configurations: A computational analysis. [2022]
Spinal direct current stimulation with locomotor training in chronic spinal cord injury. [2021]
Novel Noninvasive Spinal Neuromodulation Strategy Facilitates Recovery of Stepping after Motor Complete Paraplegia. [2022]
Effects of two different protocols of cerebellar transcranial direct current stimulation combined with transcutaneous spinal direct current stimulation on robot-assisted gait training in patients with chronic supratentorial stroke: A single blind, randomized controlled trial. [2019]
6.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Transcutaneous electrical stimulation of the spinal cord: non-invasive tool for activation of locomotor circuitry in human]. [2012]
Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review. [2022]